NCT06113692View on ClinicalTrials.gov

A Study on the Clinical Course, Outcomes and Risk Factors of Myocarditis and Pericarditis After Moderna COVID-19 Vaccine

CompletedOBSERVATIONAL
Enrollment

1,169

Participants

Timeline

Start Date

March 31, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

June 30, 2025

Conditions
Myocarditis, Pericarditis
Interventions
BIOLOGICAL

mRNA-1273

intramuscular injection

Trial Locations (5)

Unknown

Aarhus University Hospital, Aarhus

University of Oslo, Oslo

IDIAP Jordi Gol, Barcelona

FISABIO, Valencia

Drug Safety Research Unit (DSRU), Southampton

Sponsors

Collaborators (1)

Julius Clinical Research
All Listed Sponsors
collaborator

Julius Clinical Research

UNKNOWN

lead

ModernaTX, Inc.

INDUSTRY